Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization

被引:0
|
作者
Kuang, Donglin [1 ]
Zhang, Nan [1 ]
Zhang, Mengfan [1 ]
Li, Hao [1 ]
Han, Xinwei [1 ]
Ren, Jianzhuang [1 ]
Duan, Xuhua [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; drug-eluting bead transcatheter arterial chemoembolization; magnetic resonance imaging; margin enhancement; morphology; MICROVASCULAR INVASION; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC-TUMORS; ABLATION; CT; MR; MICROSPHERES; PREDICTION; SURVIVAL; CANCER;
D O I
10.3389/fonc.2023.957710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). MethodsFrom January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded. ResultsIn the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of >= 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05). ConclusionsPatients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma
    Xiang, Hua
    Long, Lin
    Yao, Yuanhui
    Fang, Zhiyong
    Zhang, Zhiming
    Zhang, Yongjin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18
  • [12] Complete contrast staining of hepatocellular carcinoma during drug-eluting bead chemoembolization predicts a favorable response
    Alharbi, Sultan R.
    JOURNAL OF CLINICAL IMAGING SCIENCE, 2024, 14
  • [13] Comparison of drug-eluting bead with conventional transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a randomized clinical trial
    Zhou, Tan-Yang
    Tao, Guo-Fang
    Zhou, Guan-Hui
    Zhang, Yue-Lin
    Zhu, Tong-Yin
    Chen, Sheng-Qun
    Wang, Hong-Liang
    Wang, Bao-Quan
    Jing, Li
    Chen, Feng
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (09) : 5527 - 5537
  • [14] Comparison of liver injury and inflammatory response following conventional and drug-eluting bead transcatheter chemoembolization in hepatocellular carcinoma
    Ran You
    Bin Leng
    Chendong Wang
    Zeyu Yu
    Lingfeng Diao
    Ya Lu
    Qingyu Xu
    Guowen Yin
    Discover Oncology, 16 (1)
  • [15] Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study
    Lee, Seungsoo
    Kim, Kyoung Min
    Lee, Shin Jae
    Lee, Kwang-Hun
    Lee, Do Yun
    Kim, Man Deuk
    Kim, Do Young
    Kim, Seung Up
    Won, Jong Yun
    ACTA RADIOLOGICA, 2017, 58 (02) : 131 - 139
  • [16] Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
    Huang, Jingjun
    Huang, Wensou
    Zhan, Meixiao
    Guo, Yongjian
    Liang, Licong
    Cai, Mingyue
    Lin, Liteng
    He, Mingji
    Lian, Hui
    Lu, Ligong
    Zhu, Kangshun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 1445 - 1458
  • [17] Apparent Diffusion Coefficient as a Noninvasive Biomarker for the Early Response in Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Using Drug-eluting Beads
    Li, Basen
    Zhou, Lei
    Xu, Anhui
    Li, Qin
    Xiang, Huihua
    Huang, Yanrong
    Peng, Ling
    Xiang, Kun
    Zhang, Mingfeng
    Wang, Nan
    CURRENT MEDICAL IMAGING, 2022, 18 (11) : 1186 - 1194
  • [18] Reactivation of intraabdominal tuberculous lymphadenopathy after drug-eluting beads transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
    Murata, Yosuke
    Hiramatsu, Katsushi
    Yoshida, Yumi
    Akazawa, Yu
    Saito, Yasushi
    Nosaka, Takuto
    Ozaki, Yoshihiko
    Hayama, Ryoko
    Takahashi, Kazuto
    Naito, Tatsushi
    Ofuji, Kazuya
    Matsuda, Hidetaka
    Ohtani, Masahiro
    Nemoto, Tomoyuki
    Nakamoto, Yasunari
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2019, 12 (01) : 76 - 81
  • [19] Reactivation of intraabdominal tuberculous lymphadenopathy after drug-eluting beads transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
    Yosuke Murata
    Katsushi Hiramatsu
    Yumi Yoshida
    Yu Akazawa
    Yasushi Saito
    Takuto Nosaka
    Yoshihiko Ozaki
    Ryoko Hayama
    Kazuto Takahashi
    Tatsushi Naito
    Kazuya Ofuji
    Hidetaka Matsuda
    Masahiro Ohtani
    Tomoyuki Nemoto
    Yasunari Nakamoto
    Clinical Journal of Gastroenterology, 2019, 12 : 76 - 81
  • [20] Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion
    Nishi, Maiko
    Saeki, Issei
    Yamasaki, Takahiro
    Maeda, Masaki
    Hisanaga, Takuro
    Iwamoto, Takuya
    Matsumoto, Toshihiko
    Hidaka, Isao
    Ishikawa, Tsuyoshi
    Takami, Taro
    Sakaida, Isao
    HEPATOLOGY RESEARCH, 2018, 48 (04) : 329 - 332